4.6 Article

Circular RNA circGLIS3 promotes bladder cancer proliferation via the miR-1273f/SKP1/Cyclin D1 axis

Journal

CELL BIOLOGY AND TOXICOLOGY
Volume 38, Issue 1, Pages 129-146

Publisher

SPRINGER
DOI: 10.1007/s10565-021-09591-3

Keywords

CircGLIS3; MiR-1273f; Bladder cancer; Post-transcriptional regulation

Funding

  1. Natural Science Foundation of China [NSFC81903356]
  2. Guangxi Natural Science Foundation Innovation Research Team Project [2019GXNSFGA245002]

Ask authors/readers for more resources

Extensive research has confirmed that circRNA circGLIS3 plays an oncogene role in bladder cancer by affecting the proliferation, migration, and invasion of bladder cancer cells, as well as regulating cell cycle progression through the upregulation of cyclin D1 expression.
Extensive research confirmed that circRNA can play a regulatory role in various stages of tumors by interacting with various molecules. Identifying the differentially expressed circRNA in bladder cancer and exploring its regulatory mechanism on bladder cancer progression are urgent. In this study, we screened out a circRNA-circGLIS3 with a significant upregulation trend in both bladder cancer tissues and cells. Bioinformatics prediction results showed that circGLIS3 may be involved in multiple tumor-related pathways. Function gain and loss experiments verified circGLIS3 can affect the proliferation, migration, and invasion of bladder cancer cells in vitro. Moreover, silencing circGLIS3 inhibited bladder cancer cell growth in vivo. Subsequent research results indicated circGLIS3 regulated the expression of cyclin D1, a cell cycle-related protein, and cell cycle progression. Mechanically, circGLIS3 upregulates the expression of SKP1 by adsorbing miR-1273f and then promotes cyclin D1 expression, ultimately promoting the proliferation of bladder cancer cells. In summary, our study indicates that circGLIS3 plays an oncogene role in the development of bladder cancer and has potential to be a candidate for bladder cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available